Priscilla Lynch
Published: Saturday, October 3, 2020

Béatrice Cochener-Lamard MD
The future of artificial intelligence (AI) looks exciting to assist but not replace ophthalmologists, according to Béatrice Cochener-Lamard MD, France.
Speaking during a dedicated Clinical Research Symposium on AI during the second day of the 38th Congress of the ESCRS, Prof Cochener-Lamard outlined the development of AI in ophthalmology and the role of deep learning to assist in diagnosis, citing its successful use in diabetic retinopathy.
Looking at the latest developments, she said we are now well on the road to automatic image classification and that the use of AI will become a widespread tool in all imaging modalities (2D and 3D and beyond). Thanks to the creation of more refined algorithms the use of ‘big data’ is not always necessary now and there are “multiple additional applications” that are on the way. These include using AI as an integrated part of “screening, diagnosis, decision support and maybe even surgical help”.
“So the future looks very exciting to help ophthalmologists for sure, but never to replace us,” Prof Cochener-Lamard concluded.
Tags: ESCRS Virtual Congress 2020
Latest Articles
ESCRS Today 2025: All Eyes on Innovation
Watching out for obstacles and opportunities
Read more...
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Read more...
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Read more...
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Read more...
Supplement: ESCRS Clinical Trends Series: Presbyopia
Read more...
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Read more...
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Read more...
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.
Read more...
Should Fuchs’ Dystrophy Patients Get Premium Lenses?
Patients’ demand for premium IOLs despite contraindications pose a challenge in Fuchs’ dystrophy treatment.
Read more...
Avoiding Posterior Capsule Rupture
Imaging may help, but surgical technique is key for managing posterior polar cataracts.
Read more...